amit@unlistedkraft.in
+91-9599071664
+91-9599071664
Royalcare Super Speciality Hospitals Unlisted Shares
DRHP Status : Not Filed
155
Fundamentals About Royalcare Super Speciality Hospitals
Downloads & Investor Documents
All documents are provided for informational purposes and are subject to regulatory disclosures.
Key Financials of Royalcare Super Speciality Hospitals
| P&L Statement | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 301 | 305 | 333 | 352 |
| Cost of Material Consumed | 97 | 98 | 106 | 106 |
| Change in Inventory | 0 | 0 | -2 | 1 |
| Gross Margins | 67.77 | 67.87 | 68.77 | 69.6 |
| Employee Benefit Expenses | 53 | 54 | 54 | 65 |
| Other Expenses | 83 | 92 | 108 | 128 |
| EBITDA | 68 | 61 | 67 | 52 |
| OPM | 22.59 | 20 | 20.12 | 14.77 |
| Other Income | 4 | 5 | 5 | 8.5 |
| Finance Cost | 27 | 27 | 22 | 20 |
| D&A | 24 | 24 | 25 | 25 |
| EBIT | 44 | 37 | 42 | 27 |
| EBIT Margins | 14.62 | 12.13 | 12.61 | 7.67 |
| PBT | 21 | 16 | 24 | 16 |
| PBT Margins | 6.98 | 5.25 | 7.21 | 4.55 |
| Tax | 0 | 0 | 0 | 1 |
| PAT | 21 | 16 | 24 | 15 |
| NPM | 6.98 | 5.25 | 7.21 | 4.26 |
| EPS | 1.28 | 0.97 | 1.4 | 0.8 |
Financial Ratios |
2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating Profit Margin | 22.59 | 20 | 20.12 | 14.77 |
| Net Profit Margin | 6.98 | 5.25 | 7.21 | 4.26 |
| Earning Per Share (Diluted) | 1.28 | 0.97 | 1.4 | 0.8 |
| Assets | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Fixed Assets | 331 | 332 | 330 | 325 |
| CWIP | 10 | 12 | 82 | 285 |
| Investments | 1 | 1 | 1 | 1 |
| Trade Receivables | 9 | 17 | 23 | 23 |
| Inventory | 6.5 | 9 | 13 | 16.5 |
| Other Assets | 47.5 | 50 | 96 | 160.5 |
| Total Assets | 405 | 421 | 545 | 811 |
| Liabilities | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Share Capital | 164.37 | 164.37 | 171 | 188.65 |
| FV | 10 | 10 | 10 | 10 |
| Reserves | -46 | -31 | 24 | 129 |
| Borrowings | 256 | 243 | 291 | 425 |
| Trade Payables | 6 | 12 | 30 | 34 |
| Other Liabilities | 24.63 | 32.63 | 29 | 34.35 |
| Total Liabilities | 405 | 421 | 545 | 811 |
About Company
Royalcare Super Speciality Hospital Limited (incorporated 2012) is an unlisted public company based in Coimbatore, Tamil Nadu, focusing on comprehensive, high-end medical care. As of early 2026, it operates a significant facility in Neelambur, providing services in various medical branches. The company has a paid-up capital of ~₹205 Cr, with unlisted shares available in the market
The following table shows a 10-point analysis of Royalcare Super Speciality Hospitals Limited. We will discuss each point in detail after this table.
| Parameter | Key Numbers | Insights |
|---|---|---|
| Business Overview | Incorporated 2012 | Multi-speciality hospital providing tertiary healthcare services |
| Industry | Healthcare · Hospitals | Operates in high-growth hospital segment |
| Core Services | Inpatient · outpatient · pharmacy · diagnostics | Diversified healthcare revenue streams |
| Location | Coimbatore | Large hospital facility with advanced infrastructure |
| Revenue | ₹352.56 Cr (FY25) | Growth vs FY24 |
| Profitability | ₹15.05 Cr PAT (FY25) | Decline vs FY24 margins |
| EBITDA | Moderate margins | Pressure due to rising costs |
| Assets | ₹545+ Cr (FY24) | Strong asset base |
| Debt Position | Moderate to high | Expansion-led borrowing |
| Outlook | Expansion-driven | Growth linked to healthcare demand |
Company Overview
(i) Royalcare Super Speciality Hospitals Limited is a multi-speciality hospital chain engaged in providing advanced healthcare services including diagnostics, surgeries, and critical care.
(ii) Incorporated in 2012 and headquartered in Coimbatore, Tamil Nadu, the company operates as a public unlisted healthcare provider.
(iii) The hospital generates revenue from inpatient services, outpatient consultations, pharmacy sales, and dietary services, creating a diversified income mix.
(iv) The company has developed modern medical infrastructure and specialized departments, catering to a wide range of medical treatments.
(v) With increasing demand for quality healthcare, the company is positioned to benefit from rising healthcare expenditure and hospital infrastructure expansion in India.
Challenges in Royalcare Super Speciality Hospitals Limited’s Business
- High capital expenditure requirements: Hospital expansion and equipment investments require continuous capital infusion.
- Pressure on profitability margins: Despite revenue growth, profits declined due to rising operational costs.
- Debt and funding dependency: Expansion is supported by borrowings and external funding.
- Working capital intensive operations: Healthcare businesses require high operational spending and inventory management.
Financial Review of Royalcare Super Speciality Hospitals Limited
Here are some highlights of the financial performance of Royalcare Super Speciality Hospitals Limited over the past few years.
FY25 Performance
• Revenue from operations stood at ₹352.56 crore
• Profit before tax stood at ₹15.67 crore
• Profit after tax reported at ₹15.05 crore
• Margins declined due to higher expenses and expansion
FY24 Performance
• Revenue from operations stood at ₹332.73 crore
• Profit before tax stood at ₹24.31 crore
• Profit after tax reported at ₹24.48 crore
• Strong profitability with improved margins
FY23 Performance
• Revenue from operations stood at ₹305.48 crore
• Profit before tax stood at ₹15.56 crore
• Profit after tax reported at ₹15 crore
• Gradual growth phase
Quick Summary
Royalcare Super Speciality Hospitals Limited is a growing healthcare provider with a strong asset base and expanding operations. While the company has shown consistent revenue growth, recent margin pressure and high capital requirements remain key concerns, making it a moderate-risk, growth-oriented unlisted investment.
Click here to visit the official website of Royalcare Super Speciality Hospitals Limited.
Promoters of Royalcare Super Speciality Hospitals Limited
The following are the active promoters/leadership associated with the company:
| Name | Designation |
|---|---|
| Promoter Group | Promoters |
Shareholding Pattern of Royalcare Super Speciality Hospitals
| Name | Holding |
|---|---|
| Promoters | 45% |
| Others | 31% |
Promoters of Royalcare Super Speciality Hospitals
| Name | Designation | Experience | Linkedin Profile |
|---|---|---|---|
| Dr. K. Madeswaran | Chairman & MD | 25+ |  |
| Dr. K. Chockalingam | Director | 25+ | |
| Sri. T.Balachander | Director & CFO | 25+ | |
Latest News
Latest Post
Coming soon...
Coming soon...
Frequently Asked Questions
Royalcare Super Speciality Hospitals Limited unlisted shares are equity shares of the company that are not listed on NSE or BSE and are traded privately.
Yes, these shares can be purchased through private market platforms, subject to availability.
Yes, a demat account is required to hold these unlisted shares.
The company operates in a high-growth healthcare sector but faces margin pressure and capital intensity, making it a moderate-risk investment.
Yes, these shares can be sold in the secondary market depending on buyer availability.
Yes, as per SEBI regulations, pre-IPO investors are subject to a six-month lock-in period after listing.
If held for more than two years, gains are taxed at 20% with indexation; otherwise taxed as per income slab.
+91-9599071664
amit@unlistedkraft.in